Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, Ingenuity Systems Integrate Technologies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CLC Bio and Ingenuity Systems today announced that they are integrating certain software products for life science research.

The firms said that they will collaborate to provide interoperability between CLC Bio's enterprise and desktop solutions and Ingenuity Systems' pathway analysis software to provide researchers with array and next-generation sequencing data and knowledge analyses.

"The costs of sequencing full genomes are now at a price level where we see a lot of industries and research areas moving into high-throughput sequencing in order to benefit from the added scientific value these new technologies can provide," CLC Bio Director of Consulting Solutions Jannick Bendtsen said in a statement. "The interoperability of Ingenuity's IPA with CLC Genomics Server and CLC Genomics Workbench is a solution that will provide an efficient workflow experience for scientists working with large next-generation sequencing datasets, directly from high-performance analyses to biomarker discovery and research diagnostic development."

Financial and other terms of the alliance were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.